期刊文献+

脑膜炎败血黄杆菌的分布及耐药性分析 被引量:4

The Distribution and Drug Resistance of Flavobacterium Meningosepticum
下载PDF
导出
摘要 目的 了解我院脑膜炎败血黄杆菌的分布和耐药性。方法 统计分析我院近 4年分离到的 5 42株脑膜炎败血黄杆菌耐药情况。结果 脑膜炎败血黄杆菌主要分布在重症监护病房 (ICU) ,主要引起呼吸道感染 ,对哌拉西林 /他唑巴坦、头孢哌酮 /舒巴坦耐药率最低 ,分别为 7 4%、 11 4% ,阿莫西林 /克拉维酸为2 7 1% ,其余抗菌药物耐药率均 >40 %。结论 脑膜炎败血黄杆菌耐药率高 ,应加强耐药性监测。 Objective To understand the distribution and drug resistance of flavobaterium meningosepticum.Methods Using statistical method to analyze the status of drug resistance of 542 flavobacterium meningosepticum strains which were isolated from our hospital in the past 4 years.Results Flavobacterium meningos epticum infection mainly distributed at intensive care unit (ICU), which mostly caused the respiratory tract infection., and whose drug resistance rates were 7.4% to piperacillin/tazobactam,11.4% to cefoperazone / sulbactam, 27.1% to amoxicillin/clavulanic acid, and over 40% to other antibiotics, respectively.Conclusions Flavobacterium meningosepticum has a high drug resistance rate, of which the surveillance for drug resistance should be emphasized.
出处 《浙江预防医学》 2004年第9期3-4,共2页 Zhejiang Journal of Preventive Medicine
关键词 脑膜炎 败血黄杆菌 耐药性 菌株 药敏试验 Flavobacterium meningosepticum Drug resistance
  • 相关文献

参考文献5

  • 1Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review [ J ]. Medicine (Baltimore), 1997, 76 (1): 30-41.
  • 2Rossolini GM, Franceschini N, Lauttti L, et al. Cloning of a Cnryseooactentun (Flavobacterium) meningosepticum chromosomal gene (blaA (CME)) encoding an extended - spectrum class A betalactamase related to the Bacteroides cephalosporinases and the VEB - 1and PER beta-lactamases [J]. Antimicrob Agents Chemother, 1999,43 (9): 2193-9.
  • 3Bellais S, Poirel L, Naas T, et al. Genetic- biochemical analysis and distribution of the Ambler class A beta - lactamase CME - 2,responsible for extended - spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum [ J]. Antimicrob Agents Chemother, 2000, 44 (1): 1-9.
  • 4Rossolini GM, Franceschini N, Riccio ML, et al. Characterization and sequence of the Chryseobacterium ( Flavobacterium )meningosepticum carbapenemase: a new molecular class B betalactarnase showing a broad substrate profile [J]. Biochem J, 1998,15:332 (Pt1): 145-52.
  • 5陈吉泉,颜泽敏.金黄杆菌致下呼吸道感染的病原学和临床研究[J].中华医院感染学杂志,2003,13(10):975-977. 被引量:13

二级参考文献6

  • 1Green BT, Nolan PE. Cellulitis and bacteraemia due to Chryseobacterium indologenes[J]. J Infect, 2001, 42(3):219-220.
  • 2Nulens E, Bussels B, Bols A,et al. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device[J]. Clin Microbiol Infect, 2001,7(7) : 391-393.
  • 3Pan HJ, Teng LJ, Chen YC, etal. High protease activity of Chryseobacterium indologenes isolates associated with invasive infection[J]. J Microbiol Immunol Infect, 2000, 33 (4) : 223-226.
  • 4Hoque SN, Graham J, Kaufmann ME, et al. Chryseobacterium(Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit [J]. J Hosp Infect, 2001, 47(3):188-192.
  • 5Ashdown LR, Previtera S. Community-acquired Flavobacterium meningosepticum pneumonia and septicaemia[J]. Med J Aust, 1992, 156(1):69-70.
  • 6Rossolini GM, Franceschini N, Riccio ML, et al. Characterization and sequence of the Chryseobacterium. (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile[J]. Biochem J, 1998, 332 ( Pt 1):145-152.

共引文献12

同被引文献27

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部